Why the study?
Does intravenous adenosine during early reperfusion reduce myocardial infarct size in a rabbit model of ischemia-reperfusion?
Does intravenous adenosine during early reperfusion reduce myocardial infarct size in a rabbit model of ischemia-reperfusion?
Intravenous adenosine during early reperfusion, with or without lignocaine, fails to limit myocardial infarct size in a rabbit model lacking significant coronary collaterals.
Answers are grounded in this paper and cite their sources.
Adenosine fails to limit infarct size in this rabbit model; leaves open its efficacy in human reperfusion or collateralized species.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Goto et al. (1991) studied Myocardial infarction (n=60). Intravenous adenosine (with or without lignocaine) vs. Untreated was evaluated on Myocardial infarct size (% of area at risk).
Synapse has enriched 10 related papers. Consider them for comparative context: